Bone Cancer Global Clinical Trials Review, H1, 2017

GlobalData's clinical trial report, “Bone Cancer Global Clinical Trials Review, H1, 2017" provides an overview of Bone Cancer clinical trials scenario. This report provides top line data relating to the clinical trials on Bone Cancer. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData’s proprietary database – Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

– The report provides a snapshot of the global clinical trials landscape

– Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status

– The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company

– The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment

– The Report provides enrollment trends for the past five years

– Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

Assists in formulating key business strategies with regards to investment

Helps in identifying prominent locations for conducting clinical trials which saves time and cost

Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities

Supports understanding of trials count and enrollment trends by country in global therapeutics market

Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials

Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Companies mentioned

Novartis AG

F. Hoffmann-La Roche Ltd

Bayer AG

Merck & Co Inc

Amgen Inc

Pfizer Inc

Takeda Pharmaceutical Company Ltd

AstraZeneca Plc

Italian Sarcoma Group

Eli Lilly and Company

Table of Contents

Table of Contents 2

List of Tables 3

List of Figures 4

Report Guidance 5

Clinical Trials by Region 6

Clinical Trials and Average Enrollment by Country 7

Top Five Countries Contributing to Clinical Trials in Asia-Pacific 10

Top Five Countries Contributing to Clinical Trials in Europe 11

Top Countries Contributing to Clinical Trials in North America 12

Top Five Countries Contributing to Clinical Trials in Middle East and Africa 13

Top Five Countries Contributing to Clinical Trials in Central and South America 14

Clinical Trials by G7 Countries: Proportion of Bone Cancer to Oncology Clinical Trials 15

Clinical Trials by Phase in G7 Countries 16

Clinical Trials in G7 Countries by Trial Status 17

Clinical Trials by E7 Countries: Proportion of Bone Cancer to Oncology Clinical Trials 19

Clinical Trials by Phase in E7 Countries 20

Clinical Trials in E7 Countries by Trial Status 21

Clinical Trials by Phase 22

In Progress Trials by Phase 23

Clinical Trials by Trial Status 24

Clinical Trials by End Point Status 26

Subjects Recruited Over a Period of Time 27

Clinical Trials by Sponsor Type 28

Prominent Sponsors 29

Top Companies Participating in Bone Cancer Therapeutics Clinical Trials 31

Prominent Drugs 33

Clinical Trial Profile Snapshots 34

Appendix 612

Abbreviations 612

Definitions 612

Research Methodology 613

Secondary Research 613

About GlobalData 614

Contact Us 614

Disclaimer 614

Source 615

List of Tables

Bone Cancer Therapeutics, Global, Clinical Trials by Region, 2017* 6

Bone Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7

Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9

Bone Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2017* 10

Bone Cancer Therapeutics Clinical Trials, Europe, Top Five Countries, 2017* 11

Bone Cancer Therapeutics Clinical Trials, North America, Top Countries, 2017* 12

Bone Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2017* 13

Bone Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2017* 14

Proportion of Bone Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15

Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Bone Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19

Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20

Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21

Bone Cancer Therapeutics, Global, Clinical Trials by Phase, 2017* 22

Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Phase 2017* 23

Bone Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24

Bone Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26

Bone Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27

Bone Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2017* 28

Bone Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29

Bone Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31

Bone Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

List of Figures

Bone Cancer Therapeutics, Global, Clinical Trials by Region (%), 2017* 6

Bone Cancer Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2017* 7

Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2017* 9

Bone Cancer Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries (%), 2017* 10

Bone Cancer Therapeutics Clinical Trials, Europe, Top Five Countries (%), 2017* 11

Bone Cancer Therapeutics Clinical Trials, North America, Top Countries (%), 2017* 12

Bone Cancer Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries (%), 2017* 13

Bone Cancer Therapeutics Clinical Trials, Central and South America, Top Five Countries (%), 2017* 14

Proportion of Bone Cancer to Oncology Clinical Trials, G7 Countries (%), 2017* 15

Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Phase, 2017* 16

Bone Cancer Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2017* 17

Proportion of Bone Cancer to Oncology Clinical Trials, E7 Countries (%), 2017* 19

Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Phase, 2017* 20

Bone Cancer Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2017* 21

Bone Cancer Therapeutics, Global, Clinical Trials by Phase (%), 2017* 22

Bone Cancer Therapeutics, Global, Clinical Trials In Progress by Phase, 2017* 23

Bone Cancer Therapeutics, Global, Clinical Trials by Trial Status, 2017* 24

Bone Cancer Therapeutics Clinical Trials, Global, by End Point Status, 2017* 26

Bone Cancer Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2012-2016 27

Bone Cancer Therapeutics Market, Global, Clinical Trials by Sponsor Type (%), 2017* 28

Bone Cancer Therapeutics Clinical Trials, Global, Key Sponsors, 2017* 29

Bone Cancer Therapeutics Clinical Trials, Global, Top Companies by Phase, 2017* 31

Bone Cancer Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2017* 33

GlobalData Methodology 613

    Pricing

Discounts available for multiple purchases.

reportstore@globaldata.com
+44 20 7947 2745

Join our mailing list

Saved reports